Skip to main content
OpenTrials
Completed

NCT Number: NCT01867476

Adherence Monitoring For Substance Abuse Clinical Trials

The purpose of this study is to determine the feasibility and accuracy of an automated adherence monitoring system, and to compare the variance between urine and oral fluid riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen interval.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Addiction & Pharmacology Research Lab, St. Luke's Hospital

San Francisco, California, 94110, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female, aged 18 to 60
  • Ability to give informed consent.
  • Be willing and able to use the study-provided phone for taking and transmitting capsule photos.

Exclusion criteria

  • Unwilling or unable to use a cell phone.
  • Any medical, psychiatric, or other condition that, in the opinion of the investigator, would preclude safe, consistent, or useful participation in the study.

Treatment and study plan

Automated Adherence Monitoring System

Other

Primary outcomes

  1. Variance between urine and oral fluid riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen interval

    Time frame: + 1, 2, 3, 4, 6 hours post dose

Sponsors and collaborators

Lead sponsor

California Pacific Medical Center Research Institute

Other

Collaborators

  • Creare, Inc.

Registry information

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Jun 4, 2013
Registry last updated
Jun 4, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.